Related Experiment Video
Updated: Feb 15, 2026

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
Published on: November 23, 2019
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells
Krishna Kalyan Kolluri1, Constantine Alifrangis2, Neelam Kumar1
1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
Abstract:
Malignant mesothelioma (MM) is poorly responsive to systemic cytotoxic chemotherapy and invariably fatal. Here we describe a screen of 94 drugs in 15 exome-sequenced MM lines and the discovery of a subset defined by loss of function of the nuclear deubiquitinase BRCA associated protein-1 (BAP1) that demonstrate heightened sensitivity to TRAIL (tumour necrosis factor-related apoptosis-inducing ligand). This association is observed across human early passage MM cultures, mouse xenografts and human tumour explants. We demonstrate that BAP1 deubiquitinase activity and its association with ASXL1 to form the Polycomb repressive deubiquitinase complex (PR-DUB) impacts TRAIL sensitivity implicating transcriptional modulation as an underlying mechanism. Death receptor agonists are well-tolerated anti-cancer agents demonstrating limited therapeutic benefit in trials without a targeting biomarker. We identify BAP1 loss-of-function mutations, which are frequent in MM, as a potential genomic stratification tool for TRAIL sensitivity with immediate and actionable therapeutic implications.
Insights
Malignant mesothelioma (MM) is a fatal cancer. Researchers found that MM with BRCA associated protein-1 (BAP1) loss-of-function mutations are sensitive to TRAIL therapy, offering a new treatment strategy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genomics
Background:
- Malignant mesothelioma (MM) exhibits poor response to chemotherapy.
- Identifying biomarkers for targeted therapies is crucial for improving MM patient outcomes.
Purpose of the Study:
- To screen drugs for efficacy against MM cell lines.
- To identify a molecular subset of MM sensitive to specific therapies.
- To investigate the role of BAP1 in drug sensitivity.
Main Methods:
- Exome sequencing of 15 MM cell lines.
- Drug screening of 94 compounds.
- Assessing sensitivity to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL).
- Investigating BAP1 function and its complex with ASXL1 (PR-DUB).
Main Results:
- A subset of MM lines with BAP1 loss-of-function mutations showed heightened sensitivity to TRAIL.
- This sensitivity was validated in human MM cultures, mouse xenografts, and tumor explants.
- BAP1 deubiquitinase activity, via the PR-DUB complex, influences TRAIL sensitivity through transcriptional modulation.
Conclusions:
- Loss-of-function mutations in BAP1 are a potential biomarker for predicting TRAIL sensitivity in MM.
- Targeting BAP1-deficient MM with TRAIL agonists offers a promising therapeutic strategy.
- Genomic stratification using BAP1 status can guide personalized treatment for malignant mesothelioma.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Line Loss
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Major Losses in Pipes
Fluid flow can be classified as laminar or turbulent, primarily based on the Reynolds number. This dimensionless number reflects the relative influence of inertial to viscous...
Minor Losses in Pipes
Valves play a significant role in generating minor losses by obstructing or redirecting the fluid flow. When a valve is closed or partially closed, it restricts the flow...
Energy Losses in Transformers
There are four main reasons for energy losses in transformers.
The first cause can be the high resistance of the...

